BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Cashflow Statement
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-15 Cr | ₹45 Cr | ₹-12 Cr | ₹-34 Cr | ₹31 Cr |
What is the latest Cash Flow from Financing Activities ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-15 Cr |
Mar2022 | ₹45 Cr |
Mar2021 | ₹-12 Cr |
Mar2020 | ₹-34 Cr |
Mar2019 | ₹31 Cr |
How is Cash Flow from Financing Activities of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-15 Cr | Negative | |
Mar2022 | ₹45 Cr | Positive | |
Mar2021 | ₹-12 Cr | Negative | |
Mar2020 | ₹-34 Cr | Negative | |
Mar2019 | ₹31 Cr | - |
Compare Cash Flow from Financing Activities of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹111.3 Cr | 6.3% | -3.8% | 5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,418.0 Cr | -1.2% | -4.7% | 58.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,680.0 Cr | 0.8% | 7.1% | 73.4% | Stock Analytics | |
CIPLA | ₹128,755.0 Cr | 2.7% | -2.8% | 32.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,720.0 Cr | 2.3% | -2.2% | 20.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,120.0 Cr | -0.7% | -5.6% | 69.2% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 6.3% |
-3.8% |
5.9% |
SENSEX | 0.6% |
-0.8% |
25.4% |
You may also like the below Video Courses